Skip to main content
TipRanks
Go Ultimate75% OFF

Aubex Corporation (3583) AI Stock Analysis

0 Followers
JP:3583

Aubex Corporation

(TSE/TYO:3583)

Select Model
Rating:63Neutral
Price Target:JPY 1,226.00â–²(6.52% Upside)
Action:reiterated
Date:10/10/26

Aubex scores in the moderate range. The dominant factor is mixed financial performance: a conservatively financed balance sheet with falling leverage and rising equity is offset by deteriorating cash flow quality, negative projected free cash flow, and a forecast -49.3% revenue drop that clouds the company's future scale. Supporting the score are favorable technicals — the stock trades above all key moving averages with positive MACD momentum and neutral RSI — and an inexpensive valuation at an 8.0x P/E with a 2.57% dividend yield. Earnings call and corporate event data were unavailable and excluded, with their weight redistributed across the remaining components.

Positive Factors
Improving Balance SheetThe substantial reduction in debt relative to equity gives Aubex greater financial flexibility and lowers balance-sheet risk. A more conservative capital structure can help the company withstand weaker trading conditions while preserving capacity for investment and other long-term capital needs.
Negative Factors
Sharp Revenue ContractionThe steep 2026 revenue decline is a material threat to Aubex’s operating scale and earnings durability. If the contraction persists, fixed operating costs may weigh more heavily on profitability, while weaker sales could reduce the company’s ability to fund growth internally.

Aubex Corporation (3583) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%JP:3583-9.08%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.15B
Dividend Yield
3.04%
Average Volume (3M)
1,198
Price to Earnings (P/E)
9.1
Beta (1Y)
0.26
Revenue Growth
-6.07%
EPS Growth
-45.17%
Country
Japan
Employees
353
Sector
Consumer Cyclical
Sector Strength
61
Industry
Department Stores

Aubex Corporation Business Overview & Revenue Model

Company Description

AuBEX CORPORATION is a global manufacturer and distributor, focusing on precision nibs and essential medical equipment. The company's nibs are meticulously crafted from diverse materials such as polyester, nylon, acrylic, and various types of plastic...

Aubex Corporation Financial Statement Overview

Summary

Aubex shows a solid balance sheet (score 68) with steady deleveraging — debt-to-equity down from 0.52 to 0.21 — and equity growth to ¥7.25B, providing a strong financial cushion. Income statement quality is moderate (score 52): revenue grew from ¥4.75B to ¥6.04B with net margins improving to ~9.5%, but the projected -49.3% FY2026 revenue decline signals a major structural change. Cash flow is the weakest pillar (score 45), with operating cash flow falling to a projected ¥329M, a deteriorating OCF-to-net-income ratio of 0.24, and free cash flow turning negative at -¥110M. Overall, financial stability is supported by low leverage, but earnings quality and cash generation trends are concerning.

Income Statement

52Neutral

Balance Sheet

68Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.73B6.01B6.04B5.39B5.32B5.49B
Gross Profit1.92B2.01B2.26B1.84B1.84B1.92B
EBITDA755.89M906.55M1.13B831.11M914.89M991.05M
Net Income344.90M573.00M580.14M436.44M469.19M536.51M
Balance Sheet
Total Assets10.21B10.17B9.89B9.76B9.35B9.48B
Cash, Cash Equivalents and Short-Term Investments2.86B2.63B2.85B2.95B2.48B2.50B
Total Debt1.54B1.52B1.49B1.84B2.20B2.33B
Total Liabilities2.92B2.91B3.18B3.50B3.51B4.07B
Stockholders Equity7.30B7.25B6.71B6.26B5.83B5.42B
Cash Flow
Free Cash Flow0-109.94M464.72M911.79M68.05M836.70M
Operating Cash Flow0329.18M637.43M1.05B338.31M1.00B
Investing Cash Flow0-443.82M-159.74M-164.65M-183.55M-189.45M
Financing Cash Flow0-148.61M-561.99M-450.60M-205.90M-265.57M

Aubex Corporation Technical Analysis

Technical Analysis SentimentNegative
Last Price1151.00

Price Trends

50DMA1335.64Negative
100DMA1313.37Negative
200DMA1290.34Negative

Market Momentum

MACD-39.35Positive
RSI22.88Positive
STOCH14.46Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3583, the sentiment is Negative. The current price of 1151.00 is below the 20-day moving average (MA) of 1307.50, below the 50-day MA of 1335.64, and below the 200-day MA of 1290.34, indicating a bearish trend. The MACD of -39.35 indicates Positive momentum. The RSI at 22.88 is Positive, neither overbought nor oversold. The STOCH value of 14.46 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3583.

Aubex Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:3583 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3583JP:358363NeutralJPY 3.28B9.13―3.04%-6.07%-45.17%
JP:8260JP:826063NeutralJPY 3.95B9.79―1.80%-3.00%-59.11%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
JP:7601JP:760153NeutralJPY 1.82B26.92――-0.91%-64.92%
JP:4558JP:455852NeutralJPY 1.96B29.57―2.76%2.41%-13.16%
JP:8217JP:821751NeutralJPY 31.35B-183.37―3.37%-0.24%92.09%
JP:7506JP:750644NeutralJPY 6.45B-65.16―1.65%-1.31%-257.02%

* Consumer Cyclical Sector Average

Performance Comparison

-10%0%10%20%JP:3583JP:4558JP:7506JP:7601JP:8217JP:8260Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3583 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3583Aubex Corporation1151.00-105.15-8.37%
JP:4558Chukyo Iyakuhin Co., Ltd.181.00-17.00-8.59%
JP:7506HOUSE OF ROSE Co.,Ltd.1367.0019.381.44%
JP:7601POPLAR Co., Ltd.151.00-21.00-12.21%
JP:8217Okuwa Co., Ltd.772.00-62.13-7.45%
JP:8260Izutsuya Co., Ltd.333.00-79.19-19.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 10, 2026